Skip to content

Cannabis and psychosis: the impact of polydrug use

Mark E. Shevlin, Eoin McElroy, Jamie Murphy, Philip Hyland, Frédérique Vallières, Ask Elklit, Mogens Nygaard Christoffersen

Drugs and Alcohol Today July 20, 2017 DOI: 10.1108/dat-03-2017-0014 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort (survey linked to administrative registry data) Peer reviewed
Sample size 4,718
Population Young Danish people aged 24
Topics Cannabis
Citations 8
Key findings Compared with no drug use, cannabis use alone did not increase the risk of psychosis, whereas the odds ratio for combined cannabis and other drug use was statistically significant. The authors suggest psychosis risk may be associated with the cumulative effect of polydrug use.

Abstract

Purpose: While research has consistently identified an association between cannabis use and psychosis, few studies have examined this relationship in a polydrug context (i.e. combining cannabis with other illicit substances). The paper aims to discuss this issue. Design/methodology/approach The present study sought to examine the association between recreational drug use (cannabis only vs polydrug) and psychotic disorders. Analysis was conducted on a large, representative survey of young Danish people aged 24 (n=4,718). Participants completed self-report measures of lifetime drug use and this information was linked to the Danish psychiatric registry system.

Findings: Multivariate binary logistic regression analysis was used to examine the association between drug use (no drug use, cannabis only, cannabis and other drug) and ICD-10 psychotic disorders, while controlling for gender and parental history of psychosis. Compared with no drug use, the use of cannabis only did not increase the risk of psychosis while the odds ratio for cannabis and other drug were statistically significant. Research limitations/implications Psychosis risk may be associated with the cumulative effect of polydrug use. Practical implications Cannabis use may be a proxy for other drug use in research studies. Originality/value This study is innovative as it uses linked self-report and administrative data for a large sample. Administrative data were used to as an objective mental health status indicator.

Comparable studies

Other cross-sectional and survey studies on cannabis, most cited first.

Study Year Design Participants
Cannabis use before age 15 and subsequent executive functioning 104 chronic cannabis users (49 early-onset before age 15, 55 late-onset after age 15)... 2011 Observational cross-sectional study n = 148
Patterns of simultaneous polysubstance use in drug using university students Drug-using university students 2006 Cross-sectional survey n = 149
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Online survey respondents 2020 Cross-sectional survey
User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study Users of hallucinogenic drugs who completed a web-based questionnaire 2010 Cross-sectional survey n = 600
Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner Adults recruited from the MAPS website and newsletter, most reporting use of various... 2012 Cross-sectional survey n = 337

Citations in the library

Explore topics